Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series

Featuring perspectives from Dr Samuel J Klempner, including the following topics: Introduction (0:00) Case: An 80-year-old woman with newly diagnosed metastatic microsatellite-stable (MSS), HER2-negative lower esophageal adenocarcinoma; PD-L1 CPS 60 — Warren S Brenner, MD (13:36) Case: A 61-year-old man with newly diagnosed HER2-negative gastroesophageal junction adenocarcinoma and worsening dysphagia with significant pain and nausea — Priya Rudolph, MD, PhD (19:05) Case: A 69-year-old man with chest pain and progressive dysphagia who is diagnosed with HER2-negative adenocarcinoma of the distal esophagus with locoregional lymph node involvement — Matthew R Strickland, MD (23:22) Case: A 55-year-old man and Iraq War veteran with MSS, HER2-positive recurrent esophageal cancer after first-line FOLFOX/trastuzumab/pembrolizumab and maintenance 5-FU/trastuzumab/pembrolizumab — Zanetta S Lamar, MD (29:52) Case: A 63-year-old man with newly diagnosed clinical Stage I lower esophageal cancer who undergoes esophagectomy; pathology reveals Stage IVA disease — Farshid Dayyani, MD, PhD (34:41) Investigator Survey (40:25) CME information and select publications